Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Todd

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Clinical Endocrinology|December 20, 2007
Measurement of basal growth hormone (GH) is a useful test of disease activity in treated acromegalic patientsC N Jayasena, C Wujanto, M Donaldson, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 29, 2000
The differential effects of galanin-(1-30) and -(3-30) on anterior pituitary hormone secretion in vivo in humansJ F Todd, C M Edwards, M A Ghatei, et al.
International Journal of Clinical Practice. Supplement|May 7, 2005
A case of excess growth hormone levelsM Shariff, W S Dhillo, L J Seal, et al.
Regulatory Peptides|November 5, 1998
Neuropeptide Y (NPY) actions on the corticotroph cell of the anterior pituitary gland are not mediated by a direct effectC J Small, J F Todd, M Ghatei, et al.
Clinical Science (London, England : 1979)|September 9, 1998
Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetesJ F Todd, C M Edwards, M A Ghatei, et al.
European Journal of Clinical Investigation|June 1, 1997
Glucagon-like peptide-1 (GLP-1): a trial of treatment in non-insulin-dependent diabetes mellitusJ F Todd, J P Wilding, C M Edwards, et al.
Endocrinology|September 29, 1998
Galanin is a paracrine inhibitor of gonadotroph function in the female ratJ F Todd, C J Small, K O Akinsanya, et al.
The British Journal of Surgery|January 23, 2009
Laparoscopic management of insulinomasA Isla, J D Arbuckle, P B Kekis, et al.
Diabetes|January 19, 1999
Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39C M Edwards, J F Todd, M Mahmoudi, et al.
European Radiology|July 15, 2009
The role of arterial stimulation and simultaneous venous sampling in addition to cross-sectional imaging for localisation of biochemically proven insulinomaD L Morganstein, D H Lewis, J Jackson, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Clinical Endocrinology|December 20, 2007
Measurement of basal growth hormone (GH) is a useful test of disease activity in treated acromegalic patientsC N Jayasena, C Wujanto, M Donaldson, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 29, 2000
The differential effects of galanin-(1-30) and -(3-30) on anterior pituitary hormone secretion in vivo in humansJ F Todd, C M Edwards, M A Ghatei, et al.
International Journal of Clinical Practice. Supplement|May 7, 2005
A case of excess growth hormone levelsM Shariff, W S Dhillo, L J Seal, et al.
Regulatory Peptides|November 5, 1998
Neuropeptide Y (NPY) actions on the corticotroph cell of the anterior pituitary gland are not mediated by a direct effectC J Small, J F Todd, M Ghatei, et al.
Clinical Science (London, England : 1979)|September 9, 1998
Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetesJ F Todd, C M Edwards, M A Ghatei, et al.
European Journal of Clinical Investigation|June 1, 1997
Glucagon-like peptide-1 (GLP-1): a trial of treatment in non-insulin-dependent diabetes mellitusJ F Todd, J P Wilding, C M Edwards, et al.
Endocrinology|September 29, 1998
Galanin is a paracrine inhibitor of gonadotroph function in the female ratJ F Todd, C J Small, K O Akinsanya, et al.
The British Journal of Surgery|January 23, 2009
Laparoscopic management of insulinomasA Isla, J D Arbuckle, P B Kekis, et al.
Diabetes|January 19, 1999
Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39C M Edwards, J F Todd, M Mahmoudi, et al.
European Radiology|July 15, 2009
The role of arterial stimulation and simultaneous venous sampling in addition to cross-sectional imaging for localisation of biochemically proven insulinomaD L Morganstein, D H Lewis, J Jackson, et al.
Pageof 4